We are live on
!
Find out more
OPW
Oxler Private Wealth Portfolio holdings
AUM
$319M
1-Year Est. Return
20.31%
This Fund
S&P 500
This Quarter
Est. Return
-14.42%
1 Year Est. Return
+20.31%
3 Year Est. Return
+87.3%
5 Year Est. Return
+102.89%
10 Year Est. Return
–
AUM
$208M
AUM Growth
-$14M
(-6.3%)
Cap. Flow
+$21.7M
Cap. Flow
% of AUM
10.45%
Top 10 Holdings %
Top 10 Hldgs %
39.39%
Holding
237
New
124
Increased
80
Reduced
6
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.72M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$4.58M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.26M |
| 4 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$1.12M |
| 5 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$646K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.73M |
| 2 |
Chevron
CVX
|
+$1.61M |
| 3 |
Check Point Software Technologies
CHKP
|
+$783K |
| 4 |
Royalty Pharma
RPRX
|
+$638K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$78.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.91% |
| 2 | Technology | 10.2% |
| 3 | Consumer Discretionary | 9.86% |
| 4 | Communication Services | 8.41% |
| 5 | Consumer Staples | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Teva Pharmaceuticals
TEVA
$40.4B
| $5.26K | ﹤0.01% |
+700
| New | +$6.1K |
|
227
Amplify Alternative Harvest ETF
MJ
$96.9M
| $5.08K | ﹤0.01% |
+73
| New | +$6.75K |
|
228
American Airlines Group
AAL
$9.82B
| $2.54K | ﹤0.01% |
+200
| New | +$3.33K |
|
|
OTLY
229
Oatly Group
OTLY
$476M
| $2.25K | ﹤0.01% |
+33
| New | +$2.58K |
|
|
B
230
Barrick Mining
B
$60.9B
| $1.36K | ﹤0.01% |
+77
| New | +$1.67K |
|
231
KKR & Co
KKR
$89.1B
| $1.17K | ﹤0.01% |
+25
| New | +$1.31K |
|
232
Peloton Interactive
PTON
$2.85B
| $954 | ﹤0.01% |
+104
| New | +$1.67K |
|
|
CYPH
233
Cypherpunk Technologies Inc
CYPH
$64M
| $625 | ﹤0.01% |
+54
| New | +$699 |
|
|
OPTN
234
DELISTED
OptiNose
OPTN
| $366 | ﹤0.01% |
+7
| New | +$257 |
|
235
ProShares Bitcoin Strategy ETF
BITO
$1.39B
| $232 | ﹤0.01% |
+20
| New | +$403 |
|
|
236
Chevron
CVX
$382B
| – | – |
-9,865
| Closed | -$1.61M |
|
|
237
Regeneron Pharmaceuticals
REGN
$72.9B
| – | – |
-2,480
| Closed | -$1.73M |
|
Similar funds
FPWM
BWS
HBW
SA
JWM
SGF
FPL
SAMT
Oxler Private Wealth's Q2 2022 Portfolio in Review
As of Q2 2022, Oxler Private Wealth held 237 positions worth $208M, down 6.3% from $222M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Oxler Private Wealth deployed $21.7M of net new capital in Q2 2022, opening 124 new positions and adding to 80 existing holdings. Its largest new stake was iShares Core US Aggregate Bond ETF: 84,815 shares worth $8.62M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $78.4K trimmed.
- Oxler Private Wealth's largest Q2 2022 buy was iShares Core US Aggregate Bond ETF: 84,815 shares worth $8.62M.
- Oxler Private Wealth added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $4.58M increase.
- Oxler Private Wealth's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $78.4K.
- Oxler Private Wealth fully exited Regeneron Pharmaceuticals in Q2 2022, selling an estimated $1.73M.
- Oxler Private Wealth's ten largest holdings make up 39% of its $208M portfolio in Q2 2022.
- Oxler Private Wealth opened 124 new positions and closed 4 in Q2 2022.
- Oxler Private Wealth's portfolio value fell 6.3% quarter-over-quarter to $208M.
Based on Oxler Private Wealth's 13F filing for Q2 2022, filed 15 Aug 2022.